Nominees & Jury

Let’s celebrate excellence in digital health

Home HRC Awards Nominees & Jury

Health Revolution Awards

The HRC Awards recognize companies in the health ecosystem that drive and promote innovation in digital health.

The Health Revolution Awards celebrate the companies driving innovation in digital health. These awards recognize those who are shaping the future of healthcare through technology, collaboration, and creativity. Discover the experts who will evaluate them.

Nominees
Jury
Oriol Sans Logoaccio
Oriol Sans

Senior Startups Manager

 

Olga Ferrer
Olga Insúa

Chief Commercial Operations Officer

Dabbaaffabcfc Gco
María José Álvarez

General Director

Nominees
Jury
Olga Ferrer
Olga Insúa

Chief Commercial Operations Officer

Dabbaaffabcfc Gco
María José Álvarez

General Director

Sara Díaz Barcelonactivalogo
Sara Díaz

Chief Executive of Strategic Sectors and Talent

Oriol Sans Logoaccio
Oriol Sans

Senior Startups Manager

 

Nominees
Jury
Olga Ferrer
Olga Insúa

Chief Commercial Operations Officer

Dabbaaffabcfc Gco
María José Álvarez

General Director

Sara Díaz Barcelonactivalogo
Sara Díaz

Chief Executive of Strategic Sectors and Talent

Oriol Sans Logoaccio
Oriol Sans

Senior Startups Manager

 

Alexanderkatzung B. Braun
Alexander Katzung

Vice President Acceleration & Innovation

Nominees
Jury
Olga Ferrer
Olga Insúa

Chief Commercial Operations Officer

Dabbaaffabcfc Gco
María José Álvarez

General Director

Sara Díaz Barcelonactivalogo
Sara Díaz

Chief Executive of Strategic Sectors and Talent

Oriol Sans Logoaccio
Oriol Sans

Senior Startups Manager

 

Nominees
Jury
Raúl G. Saraiva 3xP Global
Raúl G. Saraiva

CSO & Venture Partner

Elena Canetti Inveniam
Elena Canetti

Managing Partner

Oscar Sala 2b Labs
Oscar Sala

Founder and CEO

Albert Cot Inveniam
Albert Cot

Managing Partner

Oriol Sans
Oriol Sans

Senior Startups Manager

 

Olga
Olga Insúa

Chief Commercial Operations Officer

Dabbaaffabcfc
María José Álvarez

General Director

General Director of GCO Ventures at Grupo Catalana Occidente

 
 
Sara Díaz
Sara Díaz

Chief Executive of Strategic Sectors and Talent

Alexanderkatzung
Alexander Katzung

Vice President Acceleration & Innovation

Raúl G. Saraiva
Raúl G. Saraiva

CSO & Venture Partner

Raúl G. Saraiva is CSO & Venture Partner at 3xP Global, where he focuses on investments in health and life sciences. He previously worked at Apple Tree Partners and Portugal Ventures, building experience across therapeutics and broader healthtech. He holds a PhD in Immunology from Johns Hopkins University (2018). Over the course of his career, he has led or managed more than 15 transactions in the sector, including CellmAbs and Aethon Therapeutics.

Elena Canetti
Elena Canetti

Managing Partner

Elena Canetti is a co-founding partner of Inveniam, a Barcelona based strategic and financial advisory firm. She is an international expert in technology transfer, with extensive experience designing and managing licensing processes and commercializing technologies globally across high-tech, pharmaceutical and chemical sectors. Previously, she held senior roles at a world renowned Israeli institution, where she led the commercialization of promising technologies to international corporations and leading venture capital firms. Elena advises regional governments and academic institutions on patent commercialization and internationalization. At Inveniam, she leads strategic consulting, industrial partnerships, and supports academic spin-offs, funding strategies, and innovation development initiatives.

Oscar Sala
Oscar Sala

Founder and CEO

Oscar is a DeepTech investor and Founder of 2B Labs, focused on turning DeepTech, tech-based startups into structured, investable opportunities for international VCs.
He operates at the intersection of science, capital, and execution—designing venture builder-backed investment programs with aligned incentives, strong governance, and guaranteed capital deployment.
Previously, he was Managing Director at The Collider, a tech transfer program, bridging research and venture creation.
With 25+ years in banking, fintech, and investment, he specializes in de-risking early-stage DeepTech and scaling breakthrough technologies into companies with real market traction and financial returns.

Albert Cot
Albert Cot

Managing Partner

PhD in Bioengineering from the UPC
With more than 20 years of professional experience in DeepTech and industry-academia partnerships (Industrial and Bioengineering R&D). Two areas of expertise, both Life Sciences and Sustainability.

Institutional Revolution Partners

Join Forces with the Leaders of Health Innovation